CMBL mediates the bioactivation of prodrugs through ester bond hydrolysis:
| Prodrug | Active Metabolite | Therapeutic Class |
|---|---|---|
| Olmesartan medoxomil | Olmesartan | Angiotensin receptor blocker |
| Faropenem medoxomil | Faropenem | β-lactam antibiotic |
| Lenampicillin | Ampicillin | Penicillin antibiotic |
Key functional attributes:
Tissue distribution: Highest expression in liver cytosol, followed by kidney, small intestine, and colon
Two primary antibody types have been characterized:
Host: BALB/c mouse
Immunogen: Recombinant human CMBL (aa 1-245)
Specificity: Recognizes native and denatured CMBL
Applications: Western blot, ELISA, immunohistochemistry
Host: Rabbit
Epitope: AYPCPCDIGHRLEYGGLGREVQVEHIKAYVTKSPVDAGKAVIVIQDIFGWQLPNTRYIADMISGNGYTTIVPDFFVG
Cross-reactivity: 88% sequence identity with mouse/rat CMBL homologs
Validation: Confirmed in Western blot (0.04-0.4 μg/mL working concentration) and IHC
Critical research insights: